Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

[A severe stroke following carotid sinus massage].

van Munster CE, van Ballegoij WJ, Schroeder-Tanka JM, van den Berg-Vos RM.

Ned Tijdschr Geneeskd. 2017;161(0):D826. Dutch.

PMID:
28378696
2.

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.

McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM; ATMOSPHERE Committees Investigators.

N Engl J Med. 2016 Apr 21;374(16):1521-32. doi: 10.1056/NEJMoa1514859. Epub 2016 Apr 4.

3.

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.

Stienen S, Salah K, Moons AH, Bakx AL, van Pol PE, Schroeder-Tanka JM, Voogel AJ, Keijer JT, Kortz RA, Dickhoff C, Meregalli PG, Tijssen JG, Pinto YM, Kok WE.

Am Heart J. 2014 Jul;168(1):30-6. doi: 10.1016/j.ahj.2014.04.008. Epub 2014 Apr 23.

PMID:
24952857
4.

n-3 fatty acids and cardiovascular events after myocardial infarction.

Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group.

N Engl J Med. 2010 Nov 18;363(21):2015-26. doi: 10.1056/NEJMoa1003603. Epub 2010 Aug 28.

5.

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC; PROTECT Investigators and Committees.

N Engl J Med. 2010 Oct 7;363(15):1419-28. doi: 10.1056/NEJMoa0912613.

6.

Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial.

Geleijnse JM, Giltay EJ, Schouten EG, de Goede J, Oude Griep LM, Teitsma-Jansen AM, Katan MB, Kromhout D; Alpha Omega Trial Group.

Am Heart J. 2010 Apr;159(4):539-546.e2. doi: 10.1016/j.ahj.2009.12.033.

PMID:
20362710
7.

Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.

Weatherley BD, Cotter G, Dittrich HC, DeLucca P, Mansoor GA, Bloomfield DM, Ponikowski P, O'Connor CM, Metra M, Massie BM; PROTECT Steering Committee, Investigators, and Coordinators.

J Card Fail. 2010 Jan;16(1):25-35. doi: 10.1016/j.cardfail.2009.10.025. Epub 2009 Dec 11.

PMID:
20123315
8.

A rare complication of a pneumococcal pneumonia.

van Apeldoorn MJ, Ozdas E, Nijland F, Schroeder-Tanka JM.

Neth Heart J. 2009 Oct;17(10):393-5.

9.

Clinical results of far-field R-wave reduction with a short tip-ring electrode.

De Groot JR, Schroeder-Tanka JM, Visser J, Willems AR, De Voogt WG.

Pacing Clin Electrophysiol. 2008 Dec;31(12):1554-9. doi: 10.1111/j.1540-8159.2008.01226.x.

PMID:
19067807
10.

Reproducibility of electrocardiographic findings in patients with suspected reflex neurally-mediated syncope.

Moya A, Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Wieling W, Andresen D, Benditt DG, Garcia-Sacristán JF, Beiras X, Grovale N, Vardas P; International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group.

Am J Cardiol. 2008 Dec 1;102(11):1518-23. doi: 10.1016/j.amjcard.2008.07.043. Epub 2008 Sep 11.

PMID:
19026307
11.

Transcranial Doppler blood flow assessment in patients with mild heart failure: correlates with neuroimaging and cognitive performance.

Vogels RL, Oosterman JM, Laman DM, Gouw AA, Schroeder-Tanka JM, Scheltens P, van der Flier WM, Weinstein HC.

Congest Heart Fail. 2008 Mar-Apr;14(2):61-5.

PMID:
18401213
12.

Female gender and the risk of rupture of congenital aneurysmal fistula in adults.

Said SA, Schroeder-Tanka JM, Mulder BJ.

Congenit Heart Dis. 2008 Jan-Feb;3(1):63-8. doi: 10.1111/j.1747-0803.2007.00144.x. Review.

PMID:
18373752
13.

Neuroimaging and correlates of cognitive function among patients with heart failure.

Vogels RL, Oosterman JM, van Harten B, Gouw AA, Schroeder-Tanka JM, Scheltens P, van der Flier WM, Weinstein HC.

Dement Geriatr Cogn Disord. 2007;24(6):418-23. Epub 2007 Oct 15.

PMID:
17938570
14.

Profile of cognitive impairment in chronic heart failure.

Vogels RL, Oosterman JM, van Harten B, Scheltens P, van der Flier WM, Schroeder-Tanka JM, Weinstein HC.

J Am Geriatr Soc. 2007 Nov;55(11):1764-70. Epub 2007 Aug 28.

PMID:
17727641
15.

Brain magnetic resonance imaging abnormalities in patients with heart failure.

Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC.

Eur J Heart Fail. 2007 Oct;9(10):1003-9. Epub 2007 Aug 23.

16.

Cognitive impairment in heart failure: a systematic review of the literature.

Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC.

Eur J Heart Fail. 2007 May;9(5):440-9. Epub 2006 Dec 14. Review.

17.

Occlusion of the proximal subclavian vein complicating pacemaker lead implantation.

Riezebos RK, Schroeder-Tanka J, de Voogt WG.

Europace. 2006 Jan;8(1):42-3.

PMID:
16627407
18.

An unusual cause of electrical artefact on the ECG.

Riezebos R, Khan M, Schroeder-Tanka J.

Neth Heart J. 2006 Jan;14(1):31-32. No abstract available.

19.

'Lost and found': a coronary guidewire remnant.

Chamuleau SA, Schroeder-Tanka JM.

Neth Heart J. 2004 Sep;12(9):407-408. No abstract available.

20.

Coronary heart disease after prenatal exposure to the Dutch famine, 1944-45.

Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Schroeder-Tanka JM, van Montfrans GA, Michels RP, Bleker OP.

Heart. 2000 Dec;84(6):595-8.

Supplemental Content

Loading ...
Support Center